Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/52142
Type
ArticleCopyright
Open access
Collections
Metadata
Show full item record20
CITATIONS
20
Total citations
4
Recent citations
4.26
Field Citation Ratio
0.64
Relative Citation Ratio
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF THE FIRST 557 SUCCESSIVE PATIENTS WITH COVID-19 IN PERNAMBUCO STATE, NORTHEAST BRAZIL
SARS-CoV-2
Características clínicas
Demografia
Epidemiologia
Clínicas
https://www.arca.fiocruz.br/handle/icict/43998
Others for the Pernambuco COVID-19 Research
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil / Governo do Estado de Pernambuco. Secretaria Estadual de Saúde. Laboratório Central de Saúde Pública "Dr. Milton Bezerra Sobral". Departamento de Virologia. Recife, PE, Brasil / Universidade de Pernambuco. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Abstract
Background: South America is the current epicenter of COVID-19 pandemic. Yet, the epidemiological and clinical features of the disease have not been described in Brazil, the third most affected country in the world.
Methods: In this retrospective study, we describe the demographics, epidemiology and clinical features of the first 557 consecutive patients positive for SARS-CoV-2 living in Pernambuco state, Northeast Brazil. Results: The first COVID-19 cases occurred in the high income population. The age of infected patients ranged from 27 days to 97 years with a median of 47 years. The ratio of males to female in the SARS-CoV-2-infected group was 0.83:1. The most common symptom was cough (74.51%), followed by fever (66.79%), dyspnea (56.01%), sore throat (28.19%) and O2 saturation <95% (24.42%). 86.44% of the lethal cases were patients older than 51 years. The median time from illness onset to diagnosis was 4.0 days (range 0-39 days) Severe patients diagnosed after 14 days of symptoms onset had higher viral load than patients with mild disease. Conclusions: Our study provides important information about COVID-19 in the tropics and will assist physicians and health officials to face the current pandemics as SARS-CoV-2 continues to spread in the human population.
Keywords in Portuguese
COVID-19SARS-CoV-2
Características clínicas
Demografia
Epidemiologia
Clínicas
Publisher
Elsevier
Citation
MAGALHÃES, Jurandy Júnior Ferraz de et al. Epidemiological and clinical characteristics of the first 557 successive patients with COVID-19 in Pernambuco State, Northeast Brazil. Travel Medicine and Infectious Disease, v. 38, p. 1-9, 21 Sept. 2020.Previous version
DOI
10.1016/j.tmaid.2020.101884ISSN
1477-8939Notes
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.Others for the Pernambuco COVID-19 Research
Share